Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4791755
Max Phase: Preclinical
Molecular Formula: C29H36N2O5
Molecular Weight: 492.62
Molecule Type: Unknown
Associated Items:
ID: ALA4791755
Max Phase: Preclinical
Molecular Formula: C29H36N2O5
Molecular Weight: 492.62
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)[C@H]1[C@@H]2C=C[C@@H]3[C@H]4C/C=C\C(=O)NCCC[C@@H]5NC(=O)C(=C5O)C(=O)/C=C/[C@@H]4C[C@@H]3[C@H]2C[C@H]1C
Standard InChI: InChI=1S/C29H36N2O5/c1-15-13-21-20(26(15)16(2)32)10-9-19-18-5-3-7-25(34)30-12-4-6-23-28(35)27(29(36)31-23)24(33)11-8-17(18)14-22(19)21/h3,7-11,15,17-23,26,35H,4-6,12-14H2,1-2H3,(H,30,34)(H,31,36)/b7-3-,11-8+/t15-,17-,18+,19-,20-,21+,22+,23+,26+/m1/s1
Standard InChI Key: CZPYSRCUAFTVMI-WWBKKOLDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 492.62 | Molecular Weight (Monoisotopic): 492.2624 | AlogP: 3.19 | #Rotatable Bonds: 1 |
Polar Surface Area: 112.57 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.94 | CX Basic pKa: | CX LogP: 2.33 | CX LogD: -0.86 |
Aromatic Rings: 0 | Heavy Atoms: 36 | QED Weighted: 0.38 | Np Likeness Score: 1.55 |
1. Jiao YJ,Liu Y,Wang HX,Zhu DY,Shen YM,Li YY. (2020) Expression of the Clifednamide Biosynthetic Pathway in Streptomyces Generates 27,28-seco-Derivatives., 83 (9.0): [PMID:32915576] [10.1021/acs.jnatprod.0c00900] |
Source(1):